Acute Myeloid Leukemias: Clinical Trials

4 trials for Acute Myeloid Leukemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 unknown. 3 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Recruiting 1, Unknown 1
Phase 21Unknown 1
Phase 31Recruiting 1

Follow Acute Myeloid Leukemias: new trials by email Literature Review of Acute Myeloid Leukemias trials Research Report on Acute Myeloid Leukemias

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Revumenib, Placebo, Intensive Chemotherapy Regimen - Acute Myeloid Leukemias
Phase 3RecruitingSyndax Pharmaceuticals4682025-11-252026-10-21
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
STX-0712 - Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML)
Phase 1RecruitingSolu Therapeutics, Inc1052025-03-132026-02-09
A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
Revumenib, Chemotherapy Regimen, HiDAC - Acute Myeloid Leukemias
Phase 1Active not recruitingSyndax Pharmaceuticals962024-05-212026-09-16
Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells
Haploidentical transplantation with donor NK cells - Acute Myeloid Leukemias, Advanced Hematological Malignancies
Phase 1 / Phase 2UnknownCharite University, Berlin, Germany302001-07-012010-10-14

Narrower conditions

Leukemia, Myeloid, Acute (4)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Leukemia (4)  ·  Leukemia, Myeloid (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

revumenib (2)  ·  Drug Therapy (1)  ·  Transplantation, Haploidentical (1)

Sponsors

Syndax Pharmaceuticals (2)  ·  Charite University, Berlin, Germany (1)  ·  Solu Therapeutics, Inc (1)

Countries

United States (3)  ·  Australia (2)  ·  Canada (2)  ·  Germany (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  France (1)  ·  Georgia (1)  ·  Greece (1)  ·  Hungary (1)  ·  Israel (1)

Top investigators

Dietger Niederwieser, MD (1)  ·  Lutz Uharel, MD (1)

NIH funding

2025 (1)